ARALEN HYDROCHLORIDE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Oct 1949
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ARALEN HYDROCHLORIDE is an injectable small-molecule antimalarial agent approved in 1949 by Sanofi. The specific mechanism of action and approved indications are not detailed in available data, though historical context suggests use in malaria and related parasitic infections. This is a legacy product with a long clinical history.
LOE Approaching
Product nearing loss of exclusivity with moderate competitive pressure (30%), indicating small or transitional team structure focused on defending market share.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings indicate minimal hiring activity on this product. A career move to ARALEN HYDROCHLORIDE represents a defensive, operational role in a legacy brand facing imminent generic competition and market erosion. Best suited for professionals seeking stability in specialized tropical medicine or interested in lifecycle management rather than growth and innovation.
Brand Manager
Worked on ARALEN HYDROCHLORIDE at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.